Showing results (1461-1470 of 2,519) with videos related to
Sort By:
Pageof 252
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|May 6, 2003
Elevated blood lead resulting from maxillofacial gunshot injuries with lead ingestionJoseph L McQuirter, Stephen J Rothenberg, Gracie A Dinkins, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1988
Uptake of 19 hydrocarbon vapors inhaled by F344 ratsA R Dahl, E G Damon, J L Mauderly, et al.Annual Review of Genomics and Human Genetics|April 30, 2014
The Ethical, Legal, and Social Implications Program of the National Human Genome Research Institute: reflections on an ongoing experimentJean E McEwen, Joy T Boyer, Kathie Y Sun, et al.Current Pharmaceutical Design|July 14, 2015
The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and TherapyZofia Blach-Olszewska, Ewa Zaczynska, Kasia Gustaw-Rothenberg, et al.Drug and Alcohol Dependence|May 26, 2005
Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trialDavid McDowell, Edward V Nunes, Angela M Seracini, et al.Gaceta Medica De Mexico|September 17, 2005
[Bases to determine the dose of vitamin C in pregnancy]Esther Casanueva, María Eugenia Angulo, Sharon Goidberg, et al.The American Journal of Emergency Medicine|April 2, 2018
Emergency department boarding and adverse hospitalization outcomes among patients admitted to a general medical serviceKito Lord, Vivek Parwani, Andrew Ulrich, et al.Scientific Reports|July 12, 2018
Bioelectric-calcineurin signaling module regulates allometric growth and size of the zebrafish finJacob M Daane, Jennifer Lanni, Ina Rothenberg, et al.Blood|September 26, 2000
Analysis of the CC chemokine receptor 3 gene reveals a complex 5' exon organization, a functional role for untranslated exon 1, and a broadly active promoter with eosinophil-selective elementsN Zimmermann, B L Daugherty, J L Kavanaugh, et al.Diabetes, Obesity & Metabolism|April 5, 2011
Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjectsS Sha, D Devineni, A Ghosh, et al.Pageof 252